An Outcome of Localized HER2 Positive Breast Cancer Treated with Adjuvant Trastuzumab in Clinical Practice: Retrospective Observational Study

Musaab Raji Albayati, Haider Saadoon Alhilfi, Khalid Obiad Almohammadawi and Saad Muhsin Althaalibi
Additional contact information
Musaab Raji Albayati: Department of Medical Oncology, Al-habobi Hospital, Iraq
Khalid Obiad Almohammadawi: Department of Medicine, University of Misan, Iraq
Saad Muhsin Althaalibi: Department of Internal Medicine, Al-Sadder Teaching Hospital, Iraq

Cancer Therapy & Oncology International Journal, 2017, vol. 7, issue 3, 34-38

Abstract: HER2 positive breast cancer is well known to be associated with poor prognosis. However, the prognosis of these patients has markedly improved since the introduction of trastuzumab for the treatment of HER2 positive breast cancer in the adjuvant and metastatic setting. The aim of this study was to determine the rate and pattern of recurrences in patients with HER2 positive breast cancer treated with adjuvant trastuzumab.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555712.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555712.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:7:y:2017:i:3:p:34-38

DOI: 10.19080/CTOIJ.2017.07.555712

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().